Table 4 Relationship between CDK gene expression and HCC prognosis in GSE14520 cohort
Expression | Patient (n = 212) | OS | |||||
|---|---|---|---|---|---|---|---|
No. of events | MST (months) | HR (95% CI) | P | Adjusted HR a (95% CI) | Adjusted Pa | ||
CDK1 | Â | Â | Â | Â | Â | Â | Â |
 Low | 106 | 33 | NA | 1 |  | 1 |  |
 High | 106 | 49 | 54.8 | 1.848 (1.187–2.876) | 0.07 | 2.237 (1.424–3.514) |  < 0.001 |
CDK3 | Â | Â | Â | Â | Â | Â | Â |
 Low | 106 | 43 | NA | 1 |  | 1 |  |
 High | 106 | 39 | NA | 0.902 (0.585–1.392) | 0.642 | 1.116 (0.716–1.742) | 0.628 |
CDK4 | Â | Â | Â | Â | Â | Â | Â |
 Low | 106 | 35 | NA | 1 |  | 1 |  |
 High | 106 | 47 | NA | 1.605 (1.036–2.487) |  | 1.579 (1.013–2.461) | 0.044 |
CDK6 | Â | Â | Â | Â | Â | Â | Â |
 Low | 106 | 44 | NA | 1 |  | 1 |  |
 High | 106 | 38 | NA | 0.812 (0.526–1.254) | 0.348 | 0.88 (0.567–1.365) | 0.568 |